$DMAA Balance Sheet | Understand Stock

$DMAA

$10.87 -$0.01 (0.09%) Close

Financial Statements

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024
Current assets
Cash
Prepaid expenses and other current assets
Total current assets
Non-current assets
Cash and investments held in Trust Account
Deferred offering costs
Total non-current assets
TOTAL ASSETS
Current liabilities
Accounts payable and accrued expenses
Accrued offering costs
Extension Advance Note
Interim Note
Related Party
Total interim Note
Share redemptions payable
Total current liabilities
Deferred underwriting fee payable
Non-current liabilities
Deferred underwriting fee payable
Total non-current liabilities
Total Liabilities
Ordinary shares subject to possible redemption, 13,559,770 and 23,000,000 shares as of June 30, 2026 and December 31, 2025, respectively, at redemption value of $10.71 and $10.43 per share, respectively
Shareholders’ Deficit
Ordinary shares, $0.0001 par value; 220,000,000 shares authorized; 10,717,143(1) shares issued and outstanding, excluding 13,559,770 and 23,000,000 shares subject to redemption as of June 30, 2026 and December 31, 2025, respectively
Share subscription receivable
Additional paid-in capital
Accumulated deficit
Total Shareholders’ Deficit
TOTAL LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT

Comments